Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation

Affiliations

Tianyu Zhai: Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Tianyu Zhai: Shanghai Research Center of Biliary Tract Disease, Shanghai, China
Tianyu Zhai: Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China
Xiaoyu Zhang: Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Zhenyu Hei: Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Longyang Jin: Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Chao Han: Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Audrey Tsznam Ko: Faculty of Medicine, Imperial College London, London, United Kingdom
Xiaofeng Yu: Department of General Surgery, People’s Hospital of Gaoxin District, Suzhou, China
Jiandong Wang: Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Jiandong Wang: Shanghai Research Center of Biliary Tract Disease, Shanghai, China
Jiandong Wang: Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China

Abstract

No abstracts available.